AstraZeneca and Daiichi Sankyo continue to flesh out Enhertu plans, claiming win in earlier breast cancer line

AstraZeneca and Daiichi Sankyo have big plans for their blockbuster-in-the-making Enhertu, and the pair touted another win Monday morning in the quest to conquer the breast cancer market.